Neumora Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
NMRA
CUSIP
640979100
Type
Equity
Class
COM
Num filings
106
Total reported value, excl. options
$41.1 M
Manager Report Date Value ($000) Shares Option Type